244 related articles for article (PubMed ID: 18781409)
1. Use of Barcelona Test for cognitive assessment of patients with schizophrenia.
Gil D; Bengochea R; Arrieta M; Lastra I; Sánchez R; Alvarez A; Diego M; Prat R
Actas Esp Psiquiatr; 2008; 36(6):337-44. PubMed ID: 18781409
[TBL] [Abstract][Full Text] [Related]
2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity and specificity of a neuropsychological instrument in the evaluation of schizophrenia subtypes: a study with a Spanish speaking population].
Hilda Picasso HL; Ostrosky F; Nicolini H
Actas Esp Psiquiatr; 2005; 33(2):87-95. PubMed ID: 15768315
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in neuropsychological functioning among schizophrenia patients.
Bozikas VP; Kosmidis MH; Peltekis A; Giannakou M; Nimatoudis I; Karavatos A; Fokas K; Garyfallos G
Aust N Z J Psychiatry; 2010 Apr; 44(4):333-41. PubMed ID: 20050721
[TBL] [Abstract][Full Text] [Related]
5. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
7. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
8. [The Tunisian cognitive battery for patients with schizophrenia].
Ben Azouz O; Dellagi L; Kebir O; Johnson I; Amado I; Tabbane K
Tunis Med; 2009 Oct; 87(10):674-9. PubMed ID: 20187356
[TBL] [Abstract][Full Text] [Related]
9. Course of cognitive functioning during the stabilization phase of schizophrenia.
Klingberg S; Wittorf A; Sickinger S; Buchkremer G; Wiedemann G
J Psychiatr Res; 2008 Mar; 42(4):259-67. PubMed ID: 17400252
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure is associated with cognitive impairment in young hypertensives.
Gupta R; Solanki RK; Pathak V
World J Biol Psychiatry; 2008; 9(1):43-50. PubMed ID: 17853255
[TBL] [Abstract][Full Text] [Related]
11. Predicting domain-specific insight of schizophrenia patients from symptomatology, multiple neurocognitive functions, and personality related traits.
Ritsner MS; Blumenkrantz H
Psychiatry Res; 2007 Jan; 149(1-3):59-69. PubMed ID: 17137634
[TBL] [Abstract][Full Text] [Related]
12. Relationships of categorization on tests and daily tasks in patients with schizophrenia, post-stroke patients and healthy controls.
Josman N; Katz N
Psychiatry Res; 2006 Jan; 141(1):15-28. PubMed ID: 16352347
[TBL] [Abstract][Full Text] [Related]
13. Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia.
Dickinson D; Gold JM
Schizophr Bull; 2008 May; 34(3):423-34. PubMed ID: 17702991
[TBL] [Abstract][Full Text] [Related]
14. Predictors of medication competence in schizophrenia patients.
Heinrichs RW; Goldberg JO; Miles AA; McDermid Vaz S
Psychiatry Res; 2008 Jan; 157(1-3):47-52. PubMed ID: 17897721
[TBL] [Abstract][Full Text] [Related]
15. Dissociation of cognitive from affective components of theory of mind in schizophrenia.
Shamay-Tsoory SG; Shur S; Barcai-Goodman L; Medlovich S; Harari H; Levkovitz Y
Psychiatry Res; 2007 Jan; 149(1-3):11-23. PubMed ID: 17107716
[TBL] [Abstract][Full Text] [Related]
16. [Insight, neurocognition and psychopathology in schizophrenia].
Gil D; Bengochea R; Arrieta M; Alvarez A; Sánchez R; Diego M
Actas Esp Psiquiatr; 2006; 34(5):317-22. PubMed ID: 16991020
[TBL] [Abstract][Full Text] [Related]
17. How should DSM-V criteria for schizophrenia include cognitive impairment?
Keefe RS; Fenton WS
Schizophr Bull; 2007 Jul; 33(4):912-20. PubMed ID: 17567627
[TBL] [Abstract][Full Text] [Related]
18. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
Kern RS; Nuechterlein KH; Green MF; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Mintz J; Seidman LJ; Stover E; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):214-20. PubMed ID: 18172018
[TBL] [Abstract][Full Text] [Related]
19. Verbal memory, negative symptomatology and prediction of psychosocial functioning in schizophrenia.
Puig O; Penadés R; Gastó C; Catalán R; Torres A; Salamero M
Psychiatry Res; 2008 Feb; 158(1):11-7. PubMed ID: 18001844
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment but preservation of sexual dimorphism in cognitive abilities in chronic schizophrenia.
Halari R; Mehrotra R; Sharma T; Ng V; Kumari V
Psychiatry Res; 2006 Feb; 141(2):129-39. PubMed ID: 16427141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
